AnBogen Therapeutics
About:
Anbogen Therapeutics is a clinical-stage biotech company to creating breakthrough science that changes the life of cancer patients.
Website: https://www.anbogen.com
Top Investors: National Development Fund of Taiwan Government, KGI Venture Capital, China Development Industrial Bank (CDIB), Maxpro Ventures, TaiAn Technologies
Description:
Anbogen is a clinical-stage biotechnology company dedicated to developing precision anti-cancer drugs that hold the/promise of curing cancers and/or improving the lives of cancer patients worldwide.
Total Funding Amount:
$19.8M
Headquarters Location:
Nankang, T'ai-pei, Taiwan
Founded Date:
2019-01-01
Contact Email:
contact(AT)anbogen.com
Founders:
Number of Employees:
11-50
Last Funding Date:
2024-07-01
IPO Status:
Private
Industries:
© 2025 bioDAO.ai